Skip to content

Management of Janusandhigatavata (osteoarthritis)

A CLINICO-COMPARATIVE STUDY OF ASHVAGANDHA AND ATIBALA GHANVATI VS YOGARAJA GUGGULU IN THE MANAGEMENT OF JANU SANDHIGATA VATA (KNEE OSTEOARTHRITIS) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064466
Enrollment
140
Registered
2024-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

J S AYURVEDA MAHAVIDYALAYA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with the classical signs and symptoms of JanuSandhigatavata (OA), viz. Shula, Shotha, Stambha, Sparsha-asahyata, Sphutana, Akunchana, Prasaranevedana etc., will be taken for the study.

Exclusion criteria

Exclusion criteria: Patients suffering from Amavata, Vatarakta. Patients suffering from uncontrolled diabetes, Psoriatic arthritis, Gouty arthritis, Rheumatoid arthritis, Systemic Lupus Erythematosus (SLE), Bone TB and other major systemic disorders will be excluded. Patients of osteoarthritis already operated for joint replacement. Pregnant and lactating women will be excluded.

Design outcomes

Primary

MeasureTime frame
Primary outcome will be changes in pain and WOMAC scale. Pain will be assessed subjectively (as mentioned in signs and symptoms scoring pattern) as well as by 10 mm VAS of painTimepoint: Primary outcome will be changes in pain and WOMAC scale. Pain will be assessed subjectively (as mentioned in signs and symptoms scoring pattern) as well as by 10 mm VAS of pain

Secondary

MeasureTime frame
X-ray findings (Kellgren –lawrence system)Timepoint: BEFORE AND AFTER TREATMENT

Countries

India

Contacts

Public ContactPROF DR MANISH PATEL

J S AYURVEDA MAHAVIDYALAYA

manishayu97@yahoo.com9979589865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026